Multiple sclerosis etiology: beyond genes and environment

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Expert Review of Clinical Immunology

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1586/eci.10.11PMID 20441432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

  2012cited by this paper
• Altered expression of miR‐17‐5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients

  2010cited by this paper
• Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?

  2010cited by this paper
• MicroRNAs and cancer epigenetics: a macrorevolution

  2010cited by this paper
• Regulation of Alternative Splicing by Histone Modifications

  2010cited by this paper
• Epigenetics: molecular mechanisms and implications for disease.

  2010cited by this paper
• MGAT5 alters the severity of multiple sclerosis.

  2010cited by this paper
• Epigenetics and autoimmunity.

  2010cited by this paper
• Chromatin organization of gammaherpesvirus latent genomes.

  2010cited by this paper
• From genes to function: the next challenge to understanding multiple sclerosis

  2009cited by this paper
• Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

  2009cited by this paper
• Parental origin of sequence variants associated with complex diseases

  2009cited by this paper
• Finding the missing heritability of complex diseases

  2009cited by this paper
• Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

  2009cited by this paper
• Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.

  2009cited by this paper
• Switching on epigenetic therapy.

  2009cited by this paper
• PARP-1 Deficiency Increases the Severity of Disease in a Mouse Model of Multiple Sclerosis*

  2009cited by this paper
• Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D

  2009cited by this paper
• A molecular trio in relapse and remission in multiple sclerosis

  2009cited by this paper
• Identification of new sensitive biomarkers for the in vivo response to interferon‐β treatment in multiple sclerosis using DNA‐array evaluation

  2009cited by this paper
• Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE

  2009cited by this paper
• Nucleosome positioning as a determinant of exon recognition

  2009cited by this paper
• Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility

  2009cited by this paper
• Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis

  2009cited by this paper
• Histones: annotating chromatin.

  2009cited by this paper
• Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases

  2009cited by this paper
• Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls

  2009cited by this paper
• Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells

  2009cited by this paper
• Upregulation of Immunoglobulin‐related Genes in Cortical Sections from Multiple Sclerosis Patients

  2009cited by this paper
• Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.

  2009cited by this paper
• Alternative splicing and biological heterogeneity in prostate cancer

  2009cited by this paper
• Chromatin organization marks exon-intron structure

  2009cited by this paper
• Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression.

  2009cited by this paper
• Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

  2009cited by this paper
• Alternative Splicing and Transcriptome Profiling of Experimental Autoimmune Encephalomyelitis Using Genome-Wide Exon Arrays

  2009cited by this paper
• Common genetic variation and human traits.

  2009cited by this paper
• Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci

  2009cited by this paper
• Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients

  2009cited by this paper
• Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.

  2009cited by this paper
• Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context

  2009cited by this paper
• Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.

  2009cited by this paper
• Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

  2009cited by this paper
• Less is more: therapeutic exon skipping for Duchenne muscular dystrophy

  2009cited by this paper
• Less is more : therapeutic exon skipping for Duchenne muscular dystrophy

  2009cited by this paper
• Gene expression profiling: decoding breast cancer.

  2009cited by this paper
• Environmental factors and multiple sclerosis.

  2008cited by this paper
• EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2

  2008cited by this paper
• Methylation of class II transactivator gene promoter IV is not associated with susceptibility to Multiple Sclerosis

  2008cited by this paper
• RNA profiling of MS brain tissues.

  2008cited by this paper
• Molecular Network Analysis of T-Cell Transcriptome Suggests Aberrant Regulation of Gene Expression by NF-κB As a Biomarker for Relapse of Multiple Sclerosis

  2008cited by this paper
• Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF.

  2008cited by this paper
• MicroRNAs (miRNAs) in Neurodegenerative Diseases

  2008cited by this paper
• MicroRNAs: new regulators of immune cell development and function

  2008cited by this paper
• IFN-β1b Induces Transient and Variable Gene Expression in Relapsing-Remitting Multiple Sclerosis Patients Independent of Neutralizing Antibodies or Changes in IFN Receptor RNA Expression

  2008cited by this paper
• Multiple sclerosis

  2008cited by this paper
• CCCTC-binding Factor Activates PARP-1 Affecting DNA Methylation Machinery

  2008cited by this paper
• Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

  2008cited by this paper
• Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

  2008cited by this paper
• Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis

  2008cited by this paper
• Old suspects found guilty--the first genome profile of multiple sclerosis.

  2007cited by this paper
• MicroRNA-155 is induced during the macrophage inflammatory response

  2007cited by this paper
• Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

  2007cited by this paper
• Environmental epigenomics and disease susceptibility

  2007cited by this paper
• Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis

  2007cited by this paper
• Multiple Sclerosis

  2007cited by this paper
• Multivalent engagement of chromatin modifications by linked binding modules

  2007cited by this paper
• Risk alleles for multiple sclerosis identified by a genomewide study.

  2007cited by this paper
• Genomics in multiple sclerosis--current state and future directions.

  2007cited by this paper
• Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated

  2007cited by this paper
• The Human Endogenous Retrovirus Envelope Glycoprotein, Syncytin-1, Regulates Neuroinflammation and Its Receptor Expression in Multiple Sclerosis: A Role for Endoplasmic Reticulum Chaperones in Astrocytes1

  2007cited by this paper
• Gene expression profiles reveal homeostatic dynamics during interferon-β therapy in multiple sclerosis

  2007cited by this paper
• The DNA Binding and Catalytic Domains of Poly(ADP-Ribose) Polymerase 1 Cooperate in the Regulation of Chromatin Structure and Transcription

  2007cited by this paper
• Gene expression studies in multiple sclerosis.

  2007cited by this paper
• Functional cooperation between HP1 and DNMT1 mediates gene silencing.

  2007cited by this paper
• Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.

  2007cited by this paper
• Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

  2006cited by this paper
• Increased Citrullination of Histone H3 in Multiple Sclerosis Brain and Animal Models of Demyelination: A Role for Tumor Necrosis Factor-Induced Peptidylarginine Deiminase 4 Translocation

  2006cited by this paper
• Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.

  2006cited by this paper
• Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A

  2006cited by this paper
• Multiple sclerosis-associated retrovirus in early multiple sclerosis: a six-year follow-up of a Sardinian cohort

  2006cited by this paper
• Methylation of endogenous human retroelements in health and disease.

  2006cited by this paper
• A subtype of multiple sclerosis defined by an activated immune defense program

  2006cited by this paper
• Chromatin regulation of virus infection.

  2006cited by this paper
• DNA methylation and human disease

  2005cited by this paper
• Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.

  2005cited by this paper
• MicroRNA biogenesis: coordinated cropping and dicing

  2005cited by this paper
• Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.

  2005cited by this paper
• Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

  2005cited by this paper
• Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.

  2003cited by this paper
• Binary switches and modification cassettes in histone biology and beyond

  2003cited by this paper
• Response to Comment on "The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease"

  2003cited by this paper
• DNA methylation in systemic lupus erythematosus

  2003cited by this paper
• DNA methylation patterns and epigenetic memory.

  2002cited by this paper
• Multiple sclerosis–associated retrovirus and MS prognosis: An observational study

  2002cited by this paper
• Peptidylarginine deiminase: a candidate factor in demyelinating disease

  2002cited by this paper
• Multiple sclerosis–associated retrovirus (MSRV) in Sardinian MS patients

  2002cited by this paper
• Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

  2002cited by this paper
• The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease

  2001cited by this paper
• An embarrassment of niches: the many covalent modifications of histones in transcriptional regulation

  2001cited by this paper
• In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.

  2001cited by this paper

• Bioactive Phytochemicals in Experimental Models of Multiple Sclerosis: Mechanisms, Efficacy, and Translational Potential

  2026cites this paper
• VDR gene variants FokI and ApaI: Factors associated with susceptibility to multiple sclerosis

  2025cites this paper
• The relationship between HERVs and exogenous viral infections: A focus on the value of HERVs in disease prediction and treatment

  2025cites this paper
• Mapping the complexity of multiple sclerosis: a novel perspective on genetic, environmental, and neurobiological insights

  2025cites this paper
• Targeting the PAC1 receptor mitigates degradation of myelin and synaptic markers and diminishes locomotor deficits in the cuprizone demyelination model

  2024cites this paper
• Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression.

  2022cites this paper
• Nutrition and autoimmune diseases

  2020cites this paper
• Increased Retention of Gadolinium in the Inflamed Brain after repeated administration of gadopentetate dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF

  2020cites this paper
• Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis

  2020cites this paper
• Childhood traumas in patients with multiple sclerosis and its relationship with suicide probability (tur)

  2019cites this paper
• Non-motor symptoms in Multiple Sclerosis

  2019cites this paper
• Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset

  2018cites this paper
• EBV Infection and Vitamin D in Multiple Sclerosis Patients

  2017cites this paper
• Association between human herpesvirus & human endogenous retrovirus and MS onset & progression.

  2017cites this paper
• DNA methylation analysis in constitutional disorders: Clinical implications of the epigenome

  2016cites this paper
• Cuprizone demyelination induces a unique inflammatory response in the subventricular zone

  2016cites this paper
• Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

  2016cites this paper
• Demyelinating and Thrombotic Diseases of the Central Nervous System: Common Pathogenic and Triggering Factors

  2015cites this paper
• 18 – Epigenetics in rheumatology

  2015cites this paper
• Melatonin treatment improves primary progressive multiple sclerosis: a case report

  2015cites this paper
• Can Vitamin D Suppress Endothelial Cells Apoptosis in Multiple Sclerosis Patients?

  2013cites this paper
• [Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].

  2013cites this paper
• Cognitive impairment and “invisible symptoms” are not associated with CCSVI in MS

  2013cites this paper
• Childhood Trauma in Multiple Sclerosis: A Case-Control Study

  2012cites this paper
• Können kognitive Störungen gezielt therapiert werden?

  2012cites this paper
• Anwendung alternativer und komplementärer Therapieverfahren im klinischen Alltag am Beispiel von Patienten mit Multipler Sklerose

  2012cites this paper
• Cesarean delivery may increase the risk of multiple sclerosis

  2012cites this paper
• Elevated antibody titer against Borrelia burgdorferi in new case of multiple sclerosis patients

  2011cites this paper
• MICB gene expression on peripheral blood mononuclear cells and susceptibility to multiple sclerosis in north of Iran.

  2011cites this paper
• Isolation and characterization of recombinant U24, a membrane protein from human herpesvirus type 6

  2011cites this paper
• Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility.

  2010cites this paper